Intestinal phase of human antro-pyloro-duodenal motility: Cholinergic and CCK-mediated regulation

European Journal of Clinical Investigation

Volumn 26, Issue 7, 1996, Pages 574-583

  Katschinski, M ^a,d   Schirra, J ^a   Beglinger, C ^b   Langbein, S ^a   Wank, U ^a   D'Amato, M ^c   Arnold, R ^a  

^a UNIVERSITY HOSPITAL MARBURG   (Germany)

^b Rotta Research Laboratorium ^*

^c Rotta Research Laboratorium   (Italy)

^d Zentrum Innere Medizin   (Germany)

Author keywords

Atropine; cholecystokinin receptor antagonist; gastrin; gastrointestinal motility; loxiglumide; muscarinic receptor antagonist; pancreatic polypeptide

Indexed keywords

ATROPINE; CHOLECYSTOKININ; CHOLECYSTOKININ A RECEPTOR ANTAGONIST; GASTRIN; LOXIGLUMIDE; PANCREAS POLYPEPTIDE;

ADULT; ARTICLE; CHOLINERGIC TRANSMISSION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DUODENUM; GASTRIN RELEASE; HUMAN; HUMAN EXPERIMENT; INTESTINE CONTRACTION; INTESTINE MOTILITY; MALE; PRIORITY JOURNAL; PYLORUS; RANDOMIZED CONTROLLED TRIAL; REGULATORY MECHANISM;

EID: 0029780499     PISSN: 00142972     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2362.1996.1790522.x     Document Type: Article

References (42)

1. Makovec F, Christé R, Bani M, Pacini MA, Setnikar I, Rovati LA. New glutaramic acid derivatives with potent competitive and specific cholecystokinin-antagonistic activity. Drug Res 1985;35:1048-51.
2. Katschinski M, Schirm J, Koppelberg T et al. Effect of cholecystokinin-A-receptor blockade on oesophageal motility. Eur J Gastroenterol Hepatol 1994;6:983-9.
3. Meyer BM, Worth BA, Beglinger C et al. Role of cholecystokinin in regulation of gastrointestinal motor functions. Lancet 1989;21:12-15.
4. Fried M, Erlacher U, Schwizer W et al. Role of cholecystokinin in the regulation of gastric emptying and pancreatic enzyme secretion in humans. Studies with the cholecystokinin-receptor antagonist loxiglumide. Gastroenterology 1991;101:503-11.
5. Beglinger C, Hildebrand P, Meier R et al. A physiological role for cholecystokinin as a regulator of gastrin secretion. Gastroenterology 1992;103:490-5.
6. Hildebrand P, Beglinger C, Gyr K et al. Effects of a cholecystokinin receptor antagonist on intestinal phase of pancreatic and biliary responses in man. J Clin Invest 1990;85:640-6.
7. Meier R, Hildebrand P, Thumshirn M et al. Effect of loxiglumide, a cholecystokinin antagonist, on pancreatic polypeptide release in humans. Gastroenterology 1990;99:1757-62.
8. Adler G, Belinger C, Braun U et al. Interaction of the cholinergic system and cholecystokinin in the regulation of endogenous and exogenous stimulation of pancreatic secretion in humans. Gastroenterology 1991;100:537-43.
9. Adler G, Beglinger C, Braun U, Reinshagen M, Koop I, Schafmayer A. Cholecystokinin is a regulator of intestinal phase-stimulated PP release. Reg Peptides 1990;30:105-11.
10. Beglinger C, Hildebrand P, Adler G et al. Postprandial control of gallbladder contraction and exocrine pancreatic secretion in man. Eur J Clin Invest 1992;22:827-34.
11. Katschinski M, Dahmen G, Reinshagen M et al. Cephalic stimulation of gastrointestinal secretory and motor responses in humans. Gastroenterology 1992;103:383-91.
12. Katschinski M, Steinicke C, Reinshagen M et al. Gastrointestinal motor and secretory responses to cholinergic stimulation in humans. Differential modulation by muscarinic and cholecystokinin receptor blockade. Eur J Clin Invest 1995;25:113-22.
13. Li Y, Owyang C. Endogenous cholecystokinin stimulates pancreatic enzyme secretion via vagal afferent pathway in rats. Gastroenterology 1994;107:525-31.
14. Soudah HC, Lu Y, Hasler WL, Owyang C. Cholecystokinin at physiological levels evokes pancreatic enzyme secretion via a cholinergic pathway. Am J Physiol 1992;263:G102-G107.
15. Houghton LA, Read NW, Heddle R et al. Motor activity of the gastric antrum, pylorus, and duodenum under fasted conditions and after a liquid meal. Gastroenterology 1988;94:1276-84.
16. Fraser R, Fone D, Horowitz W, Dent J. Cholecystokinin octapeptide stimulates phasic and tonic pyloric motility in healthy humans. Gut 1993;34:33-7.
17. Hashimura E, Shimizu F, Nishino T, Imagawa K, Tateishi K, Hamaoka T. Production of a rabbit antibody specific for amino-terminal residues of cholecystokinin octapeptide (CCK-8) by selective suppression of cross-reactive antibody response. J Immunol Methods 1982;55:373-87.
18. Meyer FD, Gyr K, Häcki WH et al. The release of pancreatic polypeptide by CCK-octapeptide and some analogues in the dog. Gastroenterology 1981;80:742-7.
19. Ormsbee HS III, Telford GL, Mason GR, Required neural involvement in control of canine migrating motor complex. Am J Physiol 1979;237:E451-E456.
20. Niederau C, Karaus M. Effects of CCK receptor blockade on intestinal motor activity in conscious dogs. Am J Physiol 1991;260:G315-G324.
21. Rodriguez-Membrilla A, Martinez V, Vergara P, Mechanism of action of CCK on the regulation of small intestinal motor patterns in rats. Dig Dis Sci 1994;39:1774 (Abstract).
22. Solomon TE. Control of exocrine pancreatic secretion. In: Johnson LR, ed. Physiology of the Gastrointestinal Tract, 2nd edn. New York: Raven, 1987:1173-207.
23. Fone DR, Horowitz M, Dent J, Read NW, Heddle R. Pyloric motor response to intraduodenal dextrose involves muscarinic mechanisms. Gastroenterlogy 1989;97:83-90.
24. Fraser R, Fone DR, Heddle R, Horowitz M, Dent J. Stimulation of pyloric contractions by intraduodenal triglyceride is persistent and sensitive to atropine. J Gastroenterol Hepatol 1992;7:563-8.
25. Allescher H-D, Daniel EE, Dent J, Fox JET, Kostolanska F. Extrinsic and intrinsic neural control of pyloric sphincter pressure in the dog. J Physiol 1988;401:17-38.
26. D'Amato M, Stamford IF, Bennett A. Studies of three non-peptide cholecystokinin antagonists (devazepide, lorglumide and loxiglumide) in human isolated alimentary muscle and guinea-pig ileum. Br J Pharmacol 1991;102:391-5.
27. Allescher H-D, Daniel EE, Fox JET, Kostolanska F, Rovati LA. Effect of the novel cholecystokinin receptor antagonist CR-1392 on cholecystokinin-induced antroduodenal and pyloric motor activity in vivo. J Pharmacol Exp Ther 1989;251:1134-41.
28. Scheurer U, Varga L, Drack E, Bürki H-R, Halter F. Mechanism of action of cholecystokinin octapeptide on rat antrum, pylorus, and duodenum. Am J Physiol 1983;244:G266-G272.
29. D'Amato M, Stamford IF, Bennett A. The effects of cholecystokinin octapeptide on human isolated alimentary muscle. Br J Pharmacol 1990;100:126-30.
30. Kuwahara A, Ozawa K, Yanaihara N. Effects of cholecystokinin-octapeptide on gastric motility of anesthetized dogs. Am J Physiol 1986;251:G678-G681.
31. Forster ER, Green T, Elliot M, Bremner A, Dockray J. Gastric emptying in rats: Role of afferent neurons and cholecystokinin. Am J Physiol 1990;258:G552-556.
32. Anvari M, Malbert C-H, Horowitz M, Jamieson GG. Loxiglumide abolishes the effects of intraduodenal oleic acid on gastric motility and emptying in the pig. Neurogastroenterol Mot 1994;6:181-7.
33. Tougas G, Anvari M, Dent J, Somers S, Richard D, Stevenson GW. Relation of pyloric motility to pyloric opening and closure in healthy subjects. Gut 1992;33:466-71.
34. Martinez V, Jimenez M, Goñalons E, Vergara P. Mechanism of action of CCK in avian gastroduodenal motility: evidence for nitric oxide involvement. Am J Physiol 1993;265:G842-G850.
35. De Giorgio R, Stanghellini V, Ricci Maccarini M et al. Effects of dietary fat on postprandial gastrointestinal motility are inhibited by a cholecystokinin type A receptor antagonist. NY Acad Sci 1994;713:226-31.
36. Haba T, Sarna SK. Regulation of gastroduodenal emptying of solids by gastropyloroduodenal contractions. Am J Physiol 1993;264:G261-71.
37. Kent Lloyd KC, Raybould HE, Walsh JH. Cholecystokinin inhibits gastric acid secretion through type 'A' cholecystokinin receptors and somatostatin in rats. Am J Physiol 1992;263:G287-G292.
38. Buchan AMJ, Meloche M, Kwok YN, Kofod H. Effect of cholecystokinin and secretin on somatostatin release from cultured antral cells. Gastroenterology 1993;104:1414-19.
39. Schmidt WE, Creutzfeldt W, Höcker M et al. Cholecystokinin receptor antagonist loxiglumide modulates plasma levels of gastro-entero-pancreatic hormones in man. Feedback control of cholecystokinin and gastrin secretion. Eur J Clin Invest 1991;21:501-11.
40. Koide M, Okabayashi Y, Otsuki M. Role of endogenous bile on basal and postprandial CCK release in humans. Dig Dis Sci 1993;38:1284-90.
41. Lin HC. Abnormal intestinal feedback in disorders of gastric emptying. Dig Dis Sci 1994;39:54S-55S.
42. Grider JR, Makhlouf GM. Regional and cellular heterogeneity of cholecystokinin receptors mediating muscle contractions in the gut. Gastroenterology 1987;92:175-80.